首页|托吡酯联合拉莫三嗪治疗癫痫全身强直-阵挛性发作患者的效果

托吡酯联合拉莫三嗪治疗癫痫全身强直-阵挛性发作患者的效果

扫码查看
目的:观察托吡酯联合拉莫三嗪治疗癫痫全身强直-阵挛性发作患者的效果.方法:选取 2021 年 4 月至 2023 年 1 月商丘市第三人民医院收治的 80 例癫痫全身强直-阵挛性发作患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各 40 例.对照组予以拉莫三嗪治疗,观察组在对照组基础上联合托吡酯治疗,两组均连续治疗 3 个月.比较两组临床疗效,治疗前后认知功能[蒙特利尔认知评估量表(MoCA)]评分、神经损伤指标[神经元特异性烯醇化酶(NSE)、中枢神经特异性蛋白(S100β)、胶质纤维酸性蛋白(GFAP)、脑源性神经营养因子(BDNF)]水平,以及不良反应发生率.结果:观察组治疗总有效率为 92.50%(37/40),高于对照组的75.00%(30/40),差异有统计学意义(P<0.05);治疗后,观察组MoCA评分高于对照组,差异有统计学意义(P<0.05);治疗后,观察组NSE、S100β、GFAP水平均低于对照组,BDNF水平高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:托吡酯联合拉莫三嗪治疗癫痫全身强直-阵挛性发作患者可提高治疗总有效率和认知功能评分,改善神经损伤指标水平,效果优于单纯拉莫三嗪治疗.
Effects of Topiramate combined with Lamotrigine in treatment of patients with generalized tonic-clonic seizures of epilepsy
Objective:To observe effects of Topiramate combined with Lamotrigine in treatment of patients with generalized tonic-clonic seizures of epilepsy.Methods:80 patients with generalized tonic-clonic seizures of epilepsy admitted to Shangqiu Third People's Hospital from April 2021 to January 2023 were selected and divided into control group and observation group according to the random number table method,40 cases in each group.The control group was treated with Lamotrigine,while the observation group was treated with Topiramate on the basis of that of the control group.Both groups were treated continuously for 3 months.The clinical efficacy,the cognitive function[Montreal cognitive assessment(MoCA)]score,the nerve injury indexes[neuron-specific enolase(NSE),central nervous specific protein(S100β),glial fibrillary acidic protein(GFAP),brain-derived neurotrophic factor(BDNF)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 92.50%(37/40),which was higher than 75.00%(30/40)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the MoCA score of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of NSE,S100β and GFAP in the observation group were lower than those in the control group,the level of BDNF was higher than that in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Topiramate combined with Lamotrigine in the treatment of the patients with generalized tonic-clonic seizures can improve the total effective rate of treatment and the cognitive function scores and improve the levels of nerve injury index.Moreover,it is superior to single Lamotrigine treatment.

EpilepsyGeneralized tonic-clonic seizuresLamotrigineTopiramateCognitive functionNerve injuryAdverse reaction

胡月丽、秦文涛

展开 >

商丘市第三人民医院神经内科,河南 商丘 476000

商丘市第一人民医院急诊科,河南 商丘 476000

癫痫 全身强直-阵挛性发作 拉莫三嗪 托吡酯 认知功能 神经损伤 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(2)
  • 8